A detailed history of Natixis transactions in Boston Scientific Corp stock. As of the latest transaction made, Natixis holds 477,030 shares of BSX stock, worth $40.4 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
477,030
Previous 488,152 2.28%
Holding current value
$40.4 Million
Previous $33.4 Million 9.88%
% of portfolio
0.21%
Previous 0.18%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$67.33 - $77.71 $748,844 - $864,290
-11,122 Reduced 2.28%
477,030 $36.7 Million
Q1 2024

May 13, 2024

SELL
$57.6 - $68.62 $12.2 Million - $14.5 Million
-211,580 Reduced 30.24%
488,152 $33.4 Million
Q4 2023

Feb 13, 2024

BUY
$48.64 - $57.81 $30.5 Million - $36.3 Million
627,703 Added 871.46%
699,732 $40.5 Million
Q3 2023

Nov 14, 2023

SELL
$50.19 - $54.68 $834,358 - $909,000
-16,624 Reduced 18.75%
72,029 $3.8 Million
Q2 2023

Aug 11, 2023

SELL
$49.72 - $54.64 $15.8 Million - $17.3 Million
-316,990 Reduced 78.15%
88,653 $4.8 Million
Q1 2023

May 12, 2023

BUY
$45.09 - $50.03 $9.59 Million - $10.6 Million
212,591 Added 110.12%
405,643 $20.3 Million
Q4 2022

Feb 24, 2023

SELL
$39.56 - $47.22 $7.61 Million - $9.08 Million
-192,310 Reduced 49.9%
193,052 $8.93 Million
Q4 2022

Feb 13, 2023

BUY
$39.56 - $47.22 $10.4 Million - $12.4 Million
262,725 Added 214.23%
385,362 $17.8 Million
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $1.01 Million - $3.03 Million
-27,649 Reduced 18.4%
122,637 $4.78 Million
Q2 2022

Aug 12, 2022

SELL
$35.24 - $47.1 $15.9 Million - $21.3 Million
-451,411 Reduced 75.02%
150,286 $5.61 Million
Q1 2022

May 13, 2022

SELL
$40.9 - $45.1 $47.4 Million - $52.2 Million
-1,157,739 Reduced 65.8%
601,697 $26.6 Million
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $38.1 Million - $44.9 Million
1,000,868 Added 131.94%
1,759,436 $74.7 Million
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $13.9 Million - $15.4 Million
336,101 Added 79.56%
758,568 $32.9 Million
Q2 2021

Aug 13, 2021

BUY
$38.58 - $44.24 $11.8 Million - $13.5 Million
305,432 Added 260.97%
422,467 $18.1 Million
Q1 2021

May 14, 2021

SELL
$35.27 - $39.67 $5.68 Million - $6.39 Million
-161,086 Reduced 57.92%
117,035 $4.52 Million
Q4 2020

Feb 12, 2021

BUY
$33.15 - $41.97 $2.61 Million - $3.31 Million
78,850 Added 39.57%
278,121 $10 Million
Q3 2020

Nov 12, 2020

BUY
$34.44 - $42.23 $5.6 Million - $6.87 Million
162,633 Added 443.89%
199,271 $7.61 Million
Q2 2020

Aug 13, 2020

SELL
$30.19 - $39.11 $261,173 - $338,340
-8,651 Reduced 19.1%
36,638 $1.29 Million
Q1 2020

May 14, 2020

SELL
$25.83 - $45.71 $8.73 Million - $15.5 Million
-338,044 Reduced 88.19%
45,289 $1.48 Million
Q4 2019

Feb 14, 2020

SELL
$37.87 - $45.37 $14.1 Million - $16.9 Million
-371,789 Reduced 49.24%
383,333 $17.2 Million
Q3 2019

Nov 13, 2019

BUY
$40.31 - $43.45 $30.4 Million - $32.8 Million
755,122 New
755,122 $30.7 Million
Q2 2019

Aug 13, 2019

SELL
$34.91 - $42.98 $7.99 Million - $9.84 Million
-228,976 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$32.91 - $40.75 $1.72 Million - $2.13 Million
52,291 Added 29.6%
228,976 $8.68 Million
Q4 2018

Feb 14, 2019

BUY
$31.73 - $39.04 $2.24 Million - $2.75 Million
70,551 Added 66.47%
176,685 $6.24 Million
Q3 2018

Nov 14, 2018

BUY
$32.83 - $38.63 $1.65 Million - $1.94 Million
50,279 Added 90.02%
106,134 $4.09 Million
Q2 2018

Aug 14, 2018

SELL
$26.84 - $34.32 $3.75 Million - $4.8 Million
-139,760 Reduced 71.45%
55,855 $1.83 Million
Q1 2018

May 15, 2018

SELL
$25.2 - $28.54 $20.8 Million - $23.6 Million
-827,200 Reduced 80.87%
195,615 $5.34 Million
Q4 2017

Feb 14, 2018

BUY
$24.79 - $29.8 $22.7 Million - $27.3 Million
915,494 Added 853.04%
1,022,815 $25.4 Million
Q3 2017

Nov 14, 2017

SELL
$26.26 - $29.17 $566,401 - $629,167
-21,569 Reduced 16.73%
107,321 $3.13 Million
Q2 2017

Aug 14, 2017

BUY
N/A
128,890
128,890 $3.57 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $121B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.